Form 4 for PROK PROKIDNEY CORP.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0000950170-24-089935 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-02 | 2024-07-31 | PROK | Girolamo Todd C | CLO | C - Cnv Deriv | $0.00 | +81.9K | 163.9K | +100% | $0 |
| DM | 2024-08-02 | 2024-07-31 | PROK | Girolamo Todd C | CLO | C - Cnv Deriv | $0.00 | -163.9K | 163.9K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2024-07-31 | C | A | 81,928 | $0.00 | 163,856 | D | — | — | |
| 2 | Derivative | Common Units in ProKidney LP | 2024-07-31 | C | D | 81,928 | $0.00 | 163,857 | D | $0.00 · — to — | 81,928 Class A Ordinary Shares | (F3) The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire. |
| 3 | Derivative | Class B Ordinary Shares | 2024-07-31 | C | D | 81,928 | $0.00 | 163,857 | D | $0.00 · — to — | 81,928 Class A Ordinary Shares | (F1) The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis. (F2) The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire. |